Catalyst Wire Dossier Catalyst Wire Dossier

ATELVIA

RISENDRONATE SODIUM · Allergan, Inc.
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for ATELVIA, covering 2010-10-08 to 2026-02-03. Get the full timeline:

Most recent: FDA Approved: ATELVIA — Supplemental Application (Allergan, Inc.)

See pricing